Anonymous
Guest
Anonymous
Guest
Really seems like AMGEN has the jump on Regeneron on the the PCSK9. They are doing IVUS study, they have 4 week dosing potential at launch, they have managed care that knows what they are doing and have other contracts and relationships already in place. Thoughts?